ABA Autism denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for aba autism are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies ABA Therapy on Medical-Necessity Grounds

Aetna's medical-necessity standard for Applied Behavior Analysis therapy in autism spectrum disorder typically requires a formal ASD diagnosis, documentation of specific functional deficits or challenging behaviors, a clinical assessment supporting the recommended treatment intensity, and periodic reassessment showing meaningful progress. Denials occur most often when clinical records are incomplete, when the recommended treatment hours are not supported by a current functional behavior assessment, or when Aetna's reviewer applies a different intensity standard than the prescribing clinician.

This is among the most commonly overturned denial types in behavioral health — particularly under MHPAEA, which prohibits applying more restrictive medical-necessity criteria to behavioral health services than to analogous medical benefits.

## Why This Is Appealable

ACA §2719 and ERISA §503 provide the right to internal appeal and independent external review. MHPAEA adds a layer: if Aetna's medical-necessity criteria for ABA are more quantitatively restrictive or more heavily documented than criteria it applies to comparable medical/surgical services, that disparity is itself a separate basis for appeal and for a state or federal complaint. External review must be requested within 4 months of the final internal denial. Expedited review (72-hour decision) is available when the member's condition requires urgent treatment.

## Documentation to Gather

• ASD diagnosis documentation: Formal diagnostic evaluation from a licensed clinician, including the diagnostic tool used, date of evaluation, and severity characterization.
• Functional behavior assessment (FBA): A current FBA conducted by a Board-Certified Behavior Analyst (BCBA), identifying specific target behaviors and skill deficits that ABA is designed to address.
• Individualized treatment plan: The ABA treatment plan with behavioral goals, recommended service intensity (hours per week), and the clinical rationale for that intensity level.
• Progress notes (for ongoing treatment): If this is a continuation denial, prior progress data showing measurable movement toward treatment goals.
• Prescriber medical-necessity letter: A letter from the treating physician or BCBA explaining, in terms specific to this patient's presentation, why ABA at the recommended intensity is medically necessary.

## Criteria-Mapping Structure

Obtain Aetna's current clinical policy bulletin for ABA therapy (available on Aetna's provider portal). List each medical-necessity criterion in the left column. In the right column, cite the specific record — FBA finding, diagnostic result, treatment plan section, or progress note — that satisfies it. This structure makes it difficult for a reviewer to deny without addressing each element individually.

## Timeline

1. File internal appeal within 180 days of denial notice. 2. Aetna must decide within 30 days (pre-service) or 60 days (post-service). 3. Expedited review available for urgent treatment needs: 72-hour decision. 4. After final internal denial: request external review within 4 months.